TrademarkDir
MOLECULAR CANCER THERAPEUTICS
LIVE

Serial Number

76051350

Owner

AMERICAN ASSOCIATION FOR CANCER RESEARCH, INC.

Attorney

Mark A. Steiner, Esq.

First Use Date

Oct 30, 2001

Filing Date

May 18, 2000

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

MOLECULAR CANCER THERAPEUTICS Trademark

Serial Number: 76051350 • Registration: 2596253

MOLECULAR CANCER THERAPEUTICS is a trademark filed by AMERICAN ASSOCIATION FOR CANCER RESEARCH, INC. on May 18, 2000. The trademark is classified under Class 42 (Computer & Scientific), Class 16 (Paper Goods). The application is currently registered and active.

Owner Contact Info

AMERICAN ASSOCIATION FOR CANCER RESEARCH, INC. (44 trademarks)

WEST BUILDING ROOM 301
PHILADELPHIA, PA 19140

Entity Type: 03

Trademark Details

Filing Date

May 18, 2000

Registration Date

July 16, 2002

First Use Anywhere

October 30, 2001

First Use in Commerce

October 30, 2001

Goods & Services

Publications, namely journals in the field of medicine

Online publications, namely, journals in the field of medicine; [ and computer services, namely, providing online news and information in the field of medicine ]

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Dec 16, 2022 NA89
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
Dec 16, 2022 RNL2
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Dec 16, 2022 89AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Dec 16, 2022 APRE
TEAS SECTION 8 & 9 RECEIVED
Jun 2, 2022 E89R
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Jul 16, 2021 REM2
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 3, 2015 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 3, 2015 REAP
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 3, 2012 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 3, 2012 REAP
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Jul 27, 2011 RNL1
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Jul 27, 2011 89AG
TEAS SECTION 8 & 9 RECEIVED
Jul 19, 2011 E89R
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 29, 2010 TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 25, 2010 TCCA
REGISTERED - SEC. 8 (6-YR) ACCEPTED
Aug 5, 2008 8.OK
TEAS SECTION 8 RECEIVED
Jul 15, 2008 ES8R
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jul 11, 2008 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jul 11, 2008 COAR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 11, 2008 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 11, 2008 REAP
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 9, 2008 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 9, 2008 REAP
CASE FILE IN TICRS
Oct 25, 2007 CFIT
REGISTERED-SUPPLEMENTAL REGISTER
Jul 16, 2002 R.SR
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Apr 1, 2002 CNTA
USE AMENDMENT ACCEPTED
Apr 1, 2002 IUAA
AMENDMENT TO USE PROCESSING COMPLETE
Mar 20, 2002 AUPC
IU INFORMAL RESPONSE RECEIVED
Mar 8, 2002 IURF
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 8, 2002 CRFA
USE AFFIDAVIT FAILED FORMALITIES
Mar 4, 2002 IUFF
USE AMENDMENT FILED
Jan 9, 2002 IUAF
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 9, 2002 CRFA
FINAL REFUSAL MAILED
Jul 19, 2001 CNFR
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 21, 2001 CRFA
NON-FINAL ACTION MAILED
Nov 29, 2000 CNRT
ASSIGNED TO EXAMINER
Oct 27, 2000 DOCK

Related Trademarks

More from this Owner

CANCER RESEARCH

CANCER RESEARCH

CANCER EPIDEMIOLOGY, BIOMARKERS & PREVENTION

CANCER EPIDEMIOLOGY, BIOMARKERS & PREVENTION

CANCER EPIDEMIOLOGY, BIOMARKERS & PREVENTION

CANCER EPIDEMIOLOGY, BIOMARKERS & PREVENTION

CLINICAL CANCER RESEARCH

CLINICAL CANCER RESEARCH

CANCER EPIDEMIOLOGY, BIOMARKERS & PREVENTION

CANCER EPIDEMIOLOGY, BIOMARKERS & PREVENTION

CANCER RESEARCH SAVES LIVES

CANCER RESEARCH SAVES LIVES